Market Overview

UPDATE: Stifel Nicolaus Initiates IDEXX Laboratories at Hold on Valuation, Market Share Risk

Share:
Related IDXX
Jim Cramer Shares His Thoughts On IDEXX Laboratories, Express Scripts And Hanesbrands
18 Biggest Mid-Day Gainers For Wednesday
7 Stocks With Great –—-Month Performances (GuruFocus)

Stifel Nicolaus initiated coverage on IDEXX Laboratories (NASDAQ: IDXX) with a Hold rating.

Stifel Nicolaus commented, "IDEXX's dominance in what has proven to be a relatively resilient vet market is likely to continue. That said, we believe this is already reflected in the stock's premium valuation. In addition, our work uncovers some headwinds that may strengthen as we enter 2013, notably, future chemistry share losses and an unfavorable change in the distributor landscape."

IDEXX Laboratories closed at $93.89 on Wednesday.

Latest Ratings for IDXX

DateFirmActionFromTo
Sep 2016Bank of AmericaAssumesNeutral
Apr 2016Credit SuisseMaintainsOutperform
Apr 2016CL KingInitiates Coverage onNeutral

View More Analyst Ratings for IDXX
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (IDXX)

View Comments and Join the Discussion!